用化学免疫疗法治疗小细胞肺癌患者的预后因素:一项回顾性多中心研究
Takashi Hatori1,2, Takeshi Numata2, Toshihiro Shiozawa1
1Department of Respiratory Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Ibaraki, Japan.
Current oncology (Toronto, Ont.)
|November 26, 2024
概括
肝转移和低白蛋白水平是接受化疗免疫治疗的扩散期小细胞肺癌患者生存率低下的关键预测因素. 识别这些因素有助于预后和管理与免疫相关的不良事件.
科学领域:
- 在瘤学瘤学.
- 医学研究 医学研究
背景情况:
- 患有广泛阶段的小细胞肺癌 (SCLC) 是一个重大的治疗挑战.
- 化疗免疫疗法已经成为广泛阶段SCLC的治疗方式.
- 预测患者存活率对于治疗个性化至关重要.
研究的目的:
- 在广泛阶段的SCLC患者中确定整体生存 (OS) 的预后因素,这些患者接受化学免疫治疗.
- 评估已识别的预后因素与免疫相关不良事件 (irAEs) 的发生率之间的关联.
主要方法:
- 患者被分为有利的 (生存期≥24个月),中度的 (6-24个月) 和差的 (<6个月) 存活组.
- 用多变量考克斯回归分析来确定独立的预后因素.
- 评估了实验室标记物,包括中性粒细胞/淋巴细胞比率和白蛋白水平.
主要成果:
- 肝转移和白蛋白水平降低 (<3.5 mg/dL) 被确定为OS的独立不良预后因素.
- 根据这些因素,患者被分为三组,显示了生存寿命的显著差异 (18.3 vs 13.5 vs 3.8 个月; p < 0.001).
- 在缺乏这些不良预后因素的患者中观察到更高的irrAEs发病率 (36%对5%;p = 0.01).
结论:
- 肝转移和低albuminemia是显著的独立预测差的预后在广泛的阶段SCLC患者在化疗免疫治疗.
- 没有这些不利因素的患者可能会有更好的生存率,但面临着增加的irAEs风险.
- 这些发现可以为临床决策和患者管理策略提供信息.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


